BioSpace News Archive

C2i Genomics plans to make sophisticated AI-informed cancer diagnostics and tumor monitoring available throughout the world, regardless of where patients or clinical trials are located.

Phathom Pharmaceuticals, Inc. announced data from the PHALCON-HP Phase 3 study, the largest U.S. registrational trial ever conducted for H. pylori, will be presented during an oral session at the ACG 2021 Annual Scientific Meeting organized by the American College of Gastroenterology, in Las Vegas, Nevada, Oct. 22-27.

HCmed Innovations, a Taiwanese company that focuses on the development of vibrating mesh nebulizers, announced the successful completion of the first developmental milestone for the collaboration agreement with CSL Behring.

NANOBIOTIX announced first ever survival data from its priority head and neck cancer development program at the 2021 Annual Meeting of the American Society for Radiation Oncology.

Men with Stage IV breast cancer and known estrogen (ER) and progesterone receptor (PR) status benefit from surgical intervention and from trimodal therapy (systemic therapy, surgery, and radiation), according to a study presented at the virtual American College of Surgeons (ACS) Clinical Congress 2021.

Allakos Inc., a biotechnology company developing lirentelimab for the treatment of eosinophil and mast cell related diseases, announced the acceptance of six poster presentations at the upcoming American College of Gastroenterology Annual Scientific Meeting.